CLINICO-PATHOLOGICAL PROFILE OF CHRONIC MYELOID LEUKEMIA
Main Article Content
Abstract
Objective: This study was aimed to find out the clinico-pathological profile of chronic myeloid leukemia
(CML) in patients presenting to a tertiary care setting of NWFP.
Material and Methods: We retrospectively analyzed the data of patients presented with CML to
Oncology unit, Lady Reading Hospital unit from April 1997 to March 1999. Diagnosis was based both on
clinical and hematological parameters. Data for age, sex and diagnosis (including laboratory data) was
analyzed.
Results: Out of 59 patients, 34 (58%) patients were male while 25 (42%) were female. Age ranged from
20 months to 70 years (median 36.6 years). Two (3%) patients had juvenile CML. Chief complaints at
presentation were fever (65%), mass/pain left hypochondrium (63%), weakness (37%) and aches and pain
(36%). Clinical signs at presentation included splenomegaly in 98% patients, hepatomegaly in 57%
patients and anemia in 47% patients. Pathological/hematological values at presentation were: hemoglobin
< 10 gm/dl in 59%, total leucocyte count (TLC) > 200000/cumm in 41%, platelet count < 150000/cumm in
15% and >500000/cumm in 10%, bone marrow blasts <5% in 68% patients and >10% blasts in 12%
patients. Philadelphia chromosome (tested in limited cases) was positive in 11/12 (92%) cases.
Conclusion: In our study, CML tended to appear at a relatively younger age (mid-thirties) with a slight
male preponderance. Fever and mass left hypochondrium were the commonest presentations and
hepatosplenomegaly and anemia were the common signs. The incidence of thrombocythemia was lower in
our population.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.